Unique ID issued by UMIN | UMIN000021120 |
---|---|
Receipt number | R000023995 |
Scientific Title | Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery |
Date of disclosure of the study information | 2016/04/01 |
Last modified on | 2019/05/21 08:56:03 |
Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery
Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery (OCEAN-SFA study)
Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery
Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery (OCEAN-SFA study)
Japan |
peripheral arterial disease
Cardiology |
Others
NO
We will perform balloon angioplasty for treatment of de novo superficial femoral artery lesions, and we evaluate vascular responses at the site of balloon angioplasty by (OFDI). We identify the factors defining restenosis by evaluating the relationships between OFDI findings and presence of restenosis at 6 months after balloon angioplasty in this prospective registry.
Efficacy
Exploratory
Explanatory
Not applicable
presence of restenosis by ultrasound at 6 months after balloon angioplasty
Rutherford category at 6 months after balloon angioplasty
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Optical Frequency Domain Imaging
20 | years-old | <= |
Not applicable |
Male and Female
1)patients diagnosed as peripheral arterial disease and scheduled endvascular therapy for de novo superficial femoral artery lesions
2)patients aged over 20 years at the time of informed consent
3)patients who can undestand this study and provide informed consent written
4)ankle brachial index 0.9
5)PAD(Tasc A or B categories)
6)PAD(Rutherford 1-5 categories)
1)terminal illness in whom life expectancy is expected to be less than 6 months
2)previous stent implantation in the
targeted SFA lesion
3)acute limb ischemia or acute thrombotic occlusion
4)patients with no arterial runoff below the knee
5)patients with uncontrollable heart failure
6)patients can not recieve antiplatelet therapy
7)female patients during pregnancy or breast-feeding
8)patients who are judged inappropriate for this trial by their attending physician
60
1st name | |
Middle name | |
Last name | Hirata Ken-ichi |
Department of Internal Medicine, Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine
7-5-2 Kusunokicho, Chuoku, Kobe-city, Hyogo
078-382-5111
hiratak@med.kobe-u.ac.jp
1st name | |
Middle name | |
Last name | Yoshiro Tsukiyama |
Department of Internal Medicine, Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine
7-5-2 Kusunokicho, Chuoku, Kobe-city, Hyogo
078-382-5111
yoshiro.tsukiyama0920@gmail.com
Department of Internal Medicine, Kobe University Graduate School of Medicine
DAIICHI SANKYO COMPANY
Profit organization
NO
2016 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2016 | Year | 02 | Month | 10 | Day |
2016 | Year | 03 | Month | 23 | Day |
2016 | Year | 04 | Month | 01 | Day |
2018 | Year | 11 | Month | 01 | Day |
2016 | Year | 02 | Month | 21 | Day |
2019 | Year | 05 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023995